In subgroup analyses, an een greater reduction of risk was seen when the treatment lasted oer 36 months, which resulted in a 29 percent reduced risk.
In subgroup analyses, an een greater reduction of risk was seen when the treatment lasted oer 36 months, which resulted in a 29 percent reduced risk.
在分组讨论分析中，他们观察到了进一步的风险降低，即当治疗时间超过36个月时，卒中风险可降低29%。